Kodiak Sciences, Inc. (KOD)
44.90
+4.49
(+11.11%)
USD |
NASDAQ |
Apr 17, 16:00
44.88
-0.02
(-0.04%)
After-Hours: 20:00
Kodiak Sciences Cash from Investing (Quarterly) : -0.043M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | -135.72M |
| Eli Lilly & Co. | -2.802B |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| Madrigal Pharmaceuticals, Inc. | 27.58M |
| ADMA Biologics, Inc. | -0.276M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -39.38M |
| Cash from Financing (Quarterly) | 177.24M |
| Free Cash Flow | -136.51M |
| Free Cash Flow Per Share (Quarterly) | -0.7242 |
| Free Cash Flow to Equity (Quarterly) | -36.40M |
| Free Cash Flow to Firm (Quarterly) | -39.42M |
| Free Cash Flow Yield | -5.71% |